Texas Tech School of Medicine Cancer Research Group
Stephen Wright, MD (Principal Investigator)
Associate Professor and Chief of Oncology, Amarillo VA Medical Center
Adoptive immunotherapy of ovarian and breast cancer: MUC-1 cytotoxic T lymphocytes; adoptive immunotherapy.
- Zhenyao Wang
- Jamie Ambrose
- Earl Gilmore
Mark Dobrzanski, PhD
Assistant Professor, Division of Hematology and Oncology
Research interests in tumor immunology and cancer vaccine research with an emphasis on melanoma and breast cancer. He is particularly interested in examining (i) the roles of select tumor-reactive CD8 effector T cell subpopulations in tumor immunity and their potential as therapeutic agents in disseminated malignancy and (ii) studying the mechanisms involved in tumor rejection and evasion.